Entourage Health
Corp. (
TSX-V:ENTG)
(
OTCQX:ETRGF) (
FSE:4WE)
(“
Entourage” or the “
Company”), a
Canadian producer and distributor of award-winning cannabis
products is pleased to announce the launch
of
Syndicate a
direct-to-patient medical cannabis marketplace showcasing a
portfolio of premium craft cannabis products sourced both in-house
and from third-party micro-cultivators and producers. The Company
is one of the first to launch a medical-marketplace collective of
craft producers.
Syndicate complements the Company’s popular
medical platform Starseed Medicinal which specializes as a medical
cannabis provider to clients with insurance benefits coverage. With
Syndicate, patients without insurance coverage can access a
comprehensive catalogue of cannabis products, formats, and brands
at a competitive price point. A unique model that offers an
assortment of products from various producers, including
partnerships with Greenseal Cannabis, Sitka Micro, Premium 5 and
QWest Cannabis; a collective of micro-cultivators looking to
distribute small-batch brands into the medical channel.
“Launching Syndicate as a supplementary medical
marketplace has been a long-time passion project for many of us at
Entourage because it reinforces our commitment to providing optimal
patient care with access to locally produced, quality cannabis
products within a framework of affordability,” said Nikki Thomas,
Marketing Director, Entourage. “Additionally, in supporting craft
producers with a medical outlet to share their unique offerings
with our patients, we are taking our medical business to the next
level. Our Syndicate clients will have the same patient-centric
services currently offered to our Starseed clients – all rooted in
innovation, technology and education. Empowering our patients with
a seamless online process and access to world-class customer
service provides for a safe and responsible entry-point.”
“The original purpose for launching our Company
in 2013 harkens back to our deep-seeded belief that medical
cannabis as a wellness option should be made available to all
eligible Canadians and we are proud to be partnering with these
micro-cultivators and licensed producers who share in this
mission,” said George Scorsis, CEO and Executive Chairman,
Entourage. “With Syndicate, we are returning to our roots with
access to medical cannabis at the heart of our purpose. We continue
to advocate for cannabis medicine to be an insured benefit, but we
know the reality is that not all our clients have access and this
channel is dedicated to those patients.”
Canadian medical patients in Ontario (with more
provinces to be added) can now register as Syndicate patients here.
With more than 50 products from over five local producers expected
to be available, patients may select unique products such as
infused pre-rolls, topical compounds, oils, vapes, edibles, dried
flower products and soon, cannabis-infused beverages ‘TeaPot’.
Additionally, Syndicate offers a compassionate pricing program and
fast and convenient shipping options.
Syndicate will handle the customer service,
online payments and fulfillment as Entourage continues to bring
many other partners into the fold in the coming months.
Visit Entourage’s website here to access the
latest Company updates.
About Entourage Health
Corp.
Entourage Health Corp. is the publicly traded
parent company of Entourage Brands Corp. (formerly WeedMD RX Inc.)
and CannTx Life Sciences Inc., licence holders producing and
distributing cannabis products for both the medical and adult-use
markets. The Company owns and operates a state-of-the-art hybrid
greenhouse and processing facility located on 158-acres in
Strathroy, ON; a fully licensed 26,000 sq. ft. Aylmer, ON
processing facility, specializing in cannabis extraction; and a
micropropagation, tissue culture and genetics centre-of-excellence
in Guelph, Ontario. With its Starseed Medicinal medical-centric
brand and marketplace, Entourage has an industry-first, exclusive
partnership with LiUNA, the largest construction union in Canada,
who together with employers and other union groups, facilitate
access for insured medical patients. With the launch of Syndicate,
the Company now hosts another unique medical marketplace that
offers patients a collective of Canadian micro-cultivators’
products, along with the Company’s family of brands. Entourage’s
elite adult-use product portfolio includes Color Cannabis, Saturday
Cannabis and Royal City Cannabis Co.– sold across eight provincial
distribution agencies. It is the exclusive Canadian producer and
distributor of award-winning U.S.-based wellness brand Mary’s
Medicinals sold in both medical and adult-use channels. Under a
collaboration with The Boston Beer Company subsidiary, Entourage is
also the exclusive distributor of cannabis-infused beverages
‘TeaPot’ in Canada, which launched in select provinces summer
2022.
For more information, please visit us
at: www.entouragehealthcorp.com
Follow Entourage and its brands on:
LinkedIn
Twitter: Entourage, Color Cannabis, Saturday
Cannabis, Starseed, Royal City Cannabis Co. & Syndicate
Instagram: Entourage, Color Cannabis, Saturday
Cannabis, Starseed, Royal City Cannabis Co. & Syndicate
For further information, investor or
media inquiries, please contact:
Marianella delaBarreraSVP, Communications &
Corporate
Affairs416-897-6644marianella@entouragecorp.cominvestor@entouragecorp.commedia@entouragecorp.com
Forward Looking
Information: This press release contains
"forward-looking information" within the meaning of applicable
Canadian securities legislation which are based upon Entourage's
current internal expectations, estimates, projections, assumptions
and beliefs and views of future events. Forward-looking information
can be identified by the use of forward-looking terminology such as
"expect", "likely", "may", "will", "should", "intend",
"anticipate", "potential", "proposed", "estimate" and other similar
words, including negative and grammatical variations thereof, or
statements that certain events or conditions "may", "would" or
"will" happen, or by discussions of strategy.
The forward-looking information in this news
release is based upon the expectations, estimates, projections,
assumptions and views of future events which management believes to
be reasonable in the circumstances. Forward-looking information
includes estimates, plans, expectations, opinions, forecasts,
projections, targets, guidance or other statements that are not
statements of fact. Forward-looking information necessarily involve
known and unknown risks, including, without limitation, risks
associated with general economic conditions; adverse industry
events; loss of markets; future legislative and regulatory
developments; inability to access sufficient capital from internal
and external sources, and/or inability to access sufficient capital
on favourable terms; the cannabis industry
in Canada generally; the ability of Entourage to
implement its business strategies; the COVID-19 pandemic;
competition; crop failure; and other risks.
Any forward-looking information speaks only as
of the date on which it is made, and, except as required by law,
Entourage does not undertake any obligation to update or revise any
forward-looking information, whether as a result of new
information, future events or otherwise. New factors emerge from
time to time, and it is not possible for Entourage to predict all
such factors. When considering this forward-looking information,
readers should keep in mind the risk factors and other cautionary
statements in Entourage’s disclosure documents filed with the
applicable Canadian securities regulatory authorities on SEDAR at
www.sedar.com. The risk factors and other factors noted in the
disclosure documents could cause actual events or results to differ
materially from those described in any forward-looking
information.
NEITHER THE TSX VENTURE EXCHANGE NOR ITS
REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE
POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR
THE ADEQUACY OR ACCURACY OF THIS RELEASE.
Entourage Health (TSXV:ENTG)
Historical Stock Chart
From Jun 2024 to Jul 2024
Entourage Health (TSXV:ENTG)
Historical Stock Chart
From Jul 2023 to Jul 2024